Hiromi Nagashima

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

Haruhiro Saito, Tatsuro Fukuhara, Naoki Furuya et al. · The Lancet Oncology · 2019 · 636 citations · Full text

Medicine, Oncology, Pharmacology +12

Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial

Yosuke Kawashima, Tatsuro Fukuhara, Haruhiro Saito et al. · Institutional Repositories DataBase (IRDB) · 2022 · 109 citations

Medicine, Oncology, Pharmacology +14

Intra-articular pressure of the hip joint outside and inside the limbus.

H. Takechi, Hiromi Nagashima, Seiji Ito · PubMed · 1982 · 78 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

Multiple Scedosporium apiospermum abscesses in a woman survivor of a tsunami in northeastern Japan: a case report

Yutaka Nakamura, Yu Utsumi, Naomi Suzuki et al. · Journal of Medical Case Reports · 2011 · 44 citations · Full text

Medicine, Infectious Diseases, Microbiology +17

Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study

Tatsuro Fukuhara, Haruhiro Saito, Naoki Furuya et al. · EBioMedicine · 2020 · 30 citations · Full text

Medicine, Oncology, Pharmacotherapy +17